| Common Name | xaluritamig |
|---|---|
| Conjugate | Unconjugated |
| Synonyms | PRSS24, STEAP |
| Applications | Flow Cyt |
| Recommended Dilutions | Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Homo sapiens |
| IgG type | Human IgG1 – kappa |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q9UHE8 |
| Description | Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb
Price: 50μg $82.00 ; 100 μg $162.00
Product Data Dima FAQ
Images Dima FAQ

Figure 1. Flow cytometry analysis with 15μg/mL Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb (BME100208) on HEK293 cells transfected with Human STEAP1 protein (Blue histogram) or HEK293 transfected with irrelevant protein (Red histogram).
相关产品
Biosimilar reference antibodies
Biotinylated Anti-STEAP1(xaluritamig without CD3 biosimilar) mAb
SKU: BME100208B Target: STEAP1
Application: Flow Cyt
Price: 50μg $99.00 ; 100 μg $199.00
Biosimilar reference antibodies
SKU: BME100188 Target: STEAP1
Application: Flow Cyt
Price: 50μg $82.00 ; 100 μg $162.00
Biosimilar reference antibodies
SKU: BME100188B Target: STEAP1
Application: Flow Cyt
Price: 50μg $99.00 ; 100 μg $199.00
Biosimilar reference antibodies
SKU: BME100188P Target: STEAP1
Application: Flow Cyt
Price: 100 test $192.00
Overexpression Stable Cell Line
SKU: CEL100107 Target: STEAP1
Application: FACS Data
Price:Inquiry
